Streptococcal serum opacity factor increases the rate of hepatocyte uptake of human plasma high-density lipoprotein cholesterol

Biochemistry

Volumn 49, Issue 45, 2010, Pages 9866-9873

  Gillard, Baiba K ^a   Rosales, Corina ^a   Pillai, Biju K ^a   Lin, Hu Yu ^a   Courtney, Harry S ^b   Pownall, Henry J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEINS; CELL SURFACES; CHINESE HAMSTER OVARY CELLS; CHO CELL; CHOLESTEROL ESTERS; CHOLESTERYL ESTERS; CLASS B; HEPATOCYTES; HIGH-DENSITY LIPOPROTEIN CHOLESTEROLS; HIGH-DENSITY LIPOPROTEINS; HUH-7 CELLS; HUMAN HEPATOMA CELLS; HUMAN PLASMAS; LIPOPROTEIN RECEPTORS; PLASMA CHOLESTEROL; PLASMA LIPOPROTEINS; PROTEOGLYCANS; SCAVENGER RECEPTOR; STREPTOCOCCUS PYOGENES;

BODY FLUIDS; CELL MEMBRANES; CHOLESTEROL; ESTERIFICATION; ESTERS; LIPIDS; MICROEMULSIONS; OPACITY; PLASMA (HUMAN); TUMORS;

PLASMAS;

APOLIPOPROTEIN; APOLIPOPROTEIN E; CHOLESTEROL ESTER; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN RECEPTOR; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; PROTEOGLYCAN; RAP PROTEIN; SCAVENGER RECEPTOR BI;

ANIMAL CELL; ARTICLE; BACTERIAL VIRULENCE; CELL STRAIN HEPG2; CELL SURFACE; CELL TRANSFER; CHINESE HAMSTER; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; HEPATOMA CELL; HUMAN; HUMAN CELL; LIVER CELL; MICROEMULSION; MOUSE; NONHUMAN; PLASMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; STREPTOCOCCUS PYOGENES;

ANIMALS; BORON COMPOUNDS; CELL CULTURE TECHNIQUES; CHO CELLS; CHOLESTEROL ESTERS; CHOLESTEROL, HDL; CRICETINAE; CRICETULUS; HEPATOCYTES; HUMANS; KINETICS; LIVER; MICROSCOPY, CONFOCAL; PEPTIDE HYDROLASES; STREPTOCOCCUS PYOGENES; VIRULENCE;

CRICETULUS GRISEUS; STREPTOCOCCUS PYOGENES;

EID: 78149454803     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/bi101412m     Document Type: Article

References (42)

1. Cunningham, M. W. (2000) Pathogenesis of group A streptococcal infections Clin. Microbiol. Rev. 13, 470-511
2. Courtney, H. S. and Pownall, H. J. (2010) The structure and function of serum opacity factor: A unique streptococcal virulence determinant that targets high-density lipoproteins J. Biomed. Biotechnol. 2010, 956071
3. Courtney, H. S., Zhang, Y. M., Frank, M. W., and Rock, C. O. (2006) Serum opacity factor, a streptococcal virulence factor that binds to apolipoproteins A-I and A-II and disrupts high density lipoprotein structure J. Biol. Chem. 281, 5515-5521
4. Gillard, B. K., Courtney, H. S., Massey, J. B., and Pownall, H. J. (2007) Serum opacity factor unmasks human plasma high-density lipoprotein instability via selective delipidation and apolipoprotein A-I desorption Biochemistry 46, 12968-12978
5. Han, M., Gillard, B. K., Courtney, H. S., Ward, K., Rosales, C., Khant, H., Ludtke, S. J., and Pownall, H. J. (2009) Disruption of human plasma high-density lipoproteins by streptococcal serum opacity factor requires labile apolipoprotein A-I Biochemistry 48, 1481-1487
6. Courtney, H. S., Hasty, D. L., Li, Y., Chiang, H. C., Thacker, J. L., and Dale, J. B. (1999) Serum opacity factor is a major fibronectin-binding protein and a virulence determinant of M type 2 Streptococcus pyogenes Mol. Microbiol. 32, 89-98
7. Mahley, R. W. and Ji, Z. S. (1999) Remnant lipoprotein metabolism: Key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E J. Lipid Res. 40, 1-16
8. Acton, S., Rigotti, A., Landschulz, K. T., Xu, S., Hobbs, H. H., and Krieger, M. (1996) Identification of scavenger receptor SR-BI as a high density lipoprotein receptor Science 271, 518-520
9. Krieger, M. (2001) Scavenger receptor class B type I is a multiligand HDL receptor that influences diverse physiologic systems J. Clin. Invest. 108, 793-797
10. Nieland, T. J., Penman, M., Dori, L., Krieger, M., and Kirchhausen, T. (2002) Discovery of chemical inhibitors of the selective transfer of lipids mediated by the HDL receptor SR-BI Proc. Natl. Acad. Sci. U.S.A. 99, 15422-15427
11. Xie, Q., Khaoustov, V. I., Chung, C. C., Sohn, J., Krishnan, B., Lewis, D. E., and Yoffe, B. (2002) Effect of tauroursodeoxycholic acid on endoplasmic reticulum stress-induced caspase-12 activation Hepatology 36, 592-601
12. Gillard, B. K., Lin, H. Y., Massey, J. B., and Pownall, H. J. (2009) Apolipoproteins A-I, A-II and E are independently distributed among intracellular and newly secreted HDL of human hepatoma cells Biochim. Biophys. Acta 1791, 1125-1132
13. Gauthier, A., Lau, P., Zha, X., Milne, R., and McPherson, R. (2005) Cholesteryl ester transfer protein directly mediates selective uptake of high density lipoprotein cholesteryl esters by the liver Arterioscler., Thromb., Vasc. Biol. 25, 2177-2184
14. Jensen, J. K., Dolmer, K., Schar, C., and Gettins, P. G. (2009) Receptor-associated protein (RAP) has two high-affinity binding sites for the low-density lipoprotein receptor-related protein (LRP): Consequences for the chaperone functions of RAP Biochem. J. 421, 273-282
15. Vassiliou, G., Benoist, F., Lau, P., Kavaslar, G. N., and McPherson, R. (2001) The low density lipoprotein receptor-related protein contributes to selective uptake of high density lipoprotein cholesteryl esters by SW872 liposarcoma cells and primary human adipocytes J. Biol. Chem. 276, 48823-48830
16. Huff, M. W., Miller, D. B., Wolfe, B. M., Connelly, P. W., and Sawyez, C. G. (1997) Uptake of hypertriglyceridemic very low density lipoproteins and their remnants by HepG2 cells: The role of lipoprotein lipase, hepatic triglyceride lipase, and cell surface proteoglycans J. Lipid Res. 38, 1318-1333
17. Scharnagl, H., Schinker, R., Gierens, H., Nauck, M., Wieland, H., and Marz, W. (2001) Effect of atorvastatin, simvastatin, and lovastatin on the metabolism of cholesterol and triacylglycerides in HepG2 cells Biochem. Pharmacol. 62, 1545-1555
18. Mullen, P. J., Luscher, B., Scharnagl, H., Krahenbuhl, S., and Brecht, K. (2010) Effect of simvastatin on cholesterol metabolism in C2C12 myotubes and HepG2 cells, and consequences for statin-induced myopathy Biochem. Pharmacol. 79, 1200-1209
19. Rosales, C., Tang, D., Gillard, B. K., Courtney, H. S., and Pownall, H. J. (2010) Low-dose Streptococcal serum opacity factor reduces plasma cholesterol in vivo. American Heart Association's 11th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology, Chicago, IL, P357.
20. Tchoua, U., Rosales, C., Tang, D., Gillard, B. K., Vaughan, A., Lin, H. Y., Courtney, H. S., and Pownall, H. J. (2010) Serum opacity factor enhances HDL-mediated cholesterol efflux, esterification and anti-inflammatory effects Lipids (in press)
21. Innerarity, T. L., Mahley, R. W., Weisgraber, K. H., and Bersot, T. P. (1978) Apoprotein (E-A-II) complex of human plasma lipoproteins. II. Receptor binding activity of a high density lipoprotein subfraction modulated by the apo(E-A-II) complex J. Biol. Chem. 253, 6289-6295
22. Clay, M. A., Pyle, D. H., Rye, K. A., and Barter, P. J. (2000) Formation of spherical, reconstituted high density lipoproteins containing both apolipoproteins A-I and A-II is mediated by lecithin:cholesterol acyltransferase J. Biol. Chem. 275, 9019-9025
23. 12 complex, mediates high-density lipoprotein holoparticle endocytosis Proc. Natl. Acad. Sci. U.S.A. 96, 10158-10163
24. Cuchel, M. and Rader, D. J. (2006) Macrophage reverse cholesterol transport: Key to the regression of atherosclerosis? Circulation 113, 2548-2555
25. Zhong, S., Sharp, D. S., Grove, J. S., Bruce, C., Yano, K., Curb, J. D., and Tall, A. R. (1996) Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels J. Clin. Invest. 97, 2917-2923
26. Bruce, C., Sharp, D. S., and Tall, A. R. (1998) Relationship of HDL and coronary heart disease to a common amino acid polymorphism in the cholesteryl ester transfer protein in men with and without hypertriglyceridemia J. Lipid Res. 39, 1071-1078
27. Kozarsky, K. F., Donahee, M. H., Rigotti, A., Iqbal, S. N., Edelman, E. R., and Krieger, M. (1997) Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels Nature 387, 414-417
28. Wang, N., Arai, T., Ji, Y., Rinninger, F., and Tall, A. R. (1998) Liver-specific overexpression of scavenger receptor BI decreases levels of very low density lipoprotein ApoB, low density lipoprotein ApoB, and high density lipoprotein in transgenic mice J. Biol. Chem. 273, 32920-32926
29. Ueda, Y., Royer, L., Gong, E., Zhang, J., Cooper, P. N., Francone, O., and Rubin, E. M. (1999) Lower plasma levels and accelerated clearance of high density lipoprotein (HDL) and non-HDL cholesterol in scavenger receptor class B type I transgenic mice J. Biol. Chem. 274, 7165-7171
30. Ji, Y., Wang, N., Ramakrishnan, R., Sehayek, E., Huszar, D., Breslow, J. L., and Tall, A. R. (1999) Hepatic scavenger receptor BI promotes rapid clearance of high density lipoprotein free cholesterol and its transport into bile J. Biol. Chem. 274, 33398-33402
31. Sehayek, E., Ono, J. G., Shefer, S., Nguyen, L. B., Wang, N., Batta, A. K., Salen, G., Smith, J. D., Tall, A. R., and Breslow, J. L. (1998) Biliary cholesterol excretion: A novel mechanism that regulates dietary cholesterol absorption Proc. Natl. Acad. Sci. U.S.A. 95, 10194-10199
32. Arai, T., Wang, N., Bezouevski, M., Welch, C., and Tall, A. R. (1999) Decreased atherosclerosis in heterozygous low density lipoprotein receptor-deficient mice expressing the scavenger receptor BI transgene J. Biol. Chem. 274, 2366-2371
33. Ueda, Y., Gong, E., Royer, L., Cooper, P. N., Francone, O. L., and Rubin, E. M. (2000) Relationship between expression levels and atherogenesis in scavenger receptor class B, type I transgenics J. Biol. Chem. 275, 20368-20373
34. Kozarsky, K. F., Donahee, M. H., Glick, J. M., Krieger, M., and Rader, D. J. (2000) Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor-deficient mouse Arterioscler., Thromb., Vasc. Biol. 20, 721-727
35. Varban, M. L., Rinninger, F., Wang, N., Fairchild-Huntress, V., Dunmore, J. H., Fang, Q., Gosselin, M. L., Dixon, K. L., Deeds, J. D., Acton, S. L., Tall, A. R., and Huszar, D. (1998) Targeted mutation reveals a central role for SR-BI in hepatic selective uptake of high density lipoprotein cholesterol Proc. Natl. Acad. Sci. U.S.A. 95, 4619-4624
36. Covey, S. D., Krieger, M., Wang, W., Penman, M., and Trigatti, B. L. (2003) Scavenger receptor class B type I-mediated protection against atherosclerosis in LDL receptor-negative mice involves its expression in bone marrow-derived cells Arterioscler., Thromb., Vasc. Biol. 23, 1589-1594
37. Huszar, D., Varban, M. L., Rinninger, F., Feeley, R., Arai, T., Fairchild-Huntress, V., Donovan, M. J., and Tall, A. R. (2000) Increased LDL cholesterol and atherosclerosis in LDL receptor-deficient mice with attenuated expression of scavenger receptor B1 Arterioscler., Thromb., Vasc. Biol. 20, 1068-1073
38. Picardo, M., Massey, J. B., Kuhn, D. E., Gotto, A. M., Jr., Gianturco, S. H., and Pownall, H. J. (1986) Partially reassembled high density lipoproteins. Effects on cholesterol flux, synthesis, and esterification in normal human skin fibroblasts Arteriosclerosis 6, 434-441
39. Havel, R. J., Goldstein, J. L., and Brown, M. S. (1980) Lipoproteins and Lipid Transport. In The Metabolic Control of Disease (Bondy, P. K. and Rosenberg, L. E., Eds.) pp 393 - 494, Saunders Publishing, Philadelphia.
40. Morton, R. E. and Zilversmit, D. B. (1982) Purification and characterization of lipid transfer protein(s) from human lipoprotein-deficient plasma J. Lipid Res. 23, 1058-1067
41. Hesler, C. B., Swenson, T. L., and Tall, A. R. (1987) Purification and characterization of a human plasma cholesteryl ester transfer protein J. Biol. Chem. 262, 2275-2282
42. Asztalos, B. F., Horvath, K. V., Kajinami, K., Nartsupha, C., Cox, C. E., Batista, M., Schaefer, E. J., Inazu, A., and Mabuchi, H. (2004) Apolipoprotein composition of HDL in cholesteryl ester transfer protein deficiency J. Lipid Res. 45, 448-455